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Summary
One of the most prominent changes during T-cell aging in humans
is the accumulation of CD28null T cells, mainly CD8+ and also CD4+
T cells. Enhancing the functional properties of these cells may be
important as they provide an antigen-specific defense against
chronic infections. Recent studies have shown that IL-15 does in
fact play an appreciable role in CD4 memory T cells under physio-
logical conditions. We found that treatment with IL-15 increased
the frequency of elderly CD4+CD28null T cells by the preferential
proliferation of these cells compared to CD4+CD28+ T cells. IL-15
induced an activated phenotype in CD4+CD28null T cells. Although
the surface expression of IL-15R a-chain was not increased, the
transcription factor STAT-5 was preferentially activated. IL-15
augmented the cytotoxic properties of CD4+CD28null T cells by
increasing both the mRNA transcription and storage of granzyme
B and perforin for the cytolytic effector functions. Moreover,
pretreatment of CD4+CD28null T cells with IL-15 displayed a
synergistic effect on the IFN-c production in CMV-specific
responses, which was not observed in CD4+CD28+ T cells. IL-15
could play a role enhancing the effector response of CD4+CD28null
T cells against their specific chronic antigens.
Key words: CD4+CD28null T cells; chronic viral antigens;
cytotoxicity; IL-15; Immunosenescence; memory T cells.
Introduction
Aging is characterized by a reduction in adaptive responses and has a
profound impact on the T-cell compartment. Thymic involution implies a
decreased output of naı¨ve T cells, which is evident in peripheral blood and
the lymph nodes (Sauce et al., 2009; Appay et al., 2010). In contrast,
elderly donors display a marked increase in the proportion of highly
differentiated effector and memory T cells owing to a lifetime of exposure
to a variety of pathogens. One of the most prominent changes during
T-cell aging in humans is the accumulation of CD28null T-cells. Their
accumulation is partially explained by their reduced susceptibility to apop-
tosis and their oligoclonal expansions against CMV and other chronic anti-
gens (Vescovini et al., 2004; Almanzar et al., 2005; Derhovanessian et al.,
2009). Loss of CD28 expression is a hallmark of the age-associated decline
of T-cell function. Because CD28 provides a pivotal role during T-cell acti-
vation, such as inducing cytokine production (IL-2) and promoting cell pro-
liferation, lack of this costimulatory signal during activation results in a
partial activation or even an anergic state of T cells (Godlove et al., 2007).
In this way, the accumulation of CD28null T cells, particularly within the
CD8 subset, is associated with a reduced overall immune response to
pathogens and vaccines in the elderly (Saurwein-Teissl et al., 2002).
Despite CD4+ T cells are more resistant to age-related phenotypic and
functional changes (Wikby et al., 2002; Weinberger et al., 2007), a pro-
gressive increase in the percentage of CD4+ T cells that lack CD28 expres-
sion is common with increasing age in healthy individuals (Goronzy et al.,
2007; Czesnikiewicz-Guzik et al., 2008) and in patients with chronic
infections and autoimmune diseases(Komocsi et al., 2002; Fletcher et al.,
2005; Thewissen et al., 2007). Thereby, CD4+CD28null T cells can com-
prise up to 50% of the total CD4+ T-cell compartment in some individuals
older than 65 years(Vallejo et al., 2000). CD4+CD28null T cells are func-
tionally distinct from CD4+CD28+ T cells but exhibit similarities with
CD8+CD28null T cells. CD4+CD28null T cells acquire expression of several
receptors commonly associated with NK cells, secrete large amounts of
IFN-c, and express perforin and granzyme B, which convey cytotoxic capa-
bility to the cells (Appay et al., 2002; van Leeuwen et al., 2004).
Generation of long-term memory CD4+ and CD8+ T cells is dependent
upon antigenic stimulation, but their survival is antigen-independent and
requires peripherally produced cytokines, particularly those that use the
common c-chain for signaling, such as IL-15(Ku et al., 2000). The impor-
tance of IL-15 in memory T cells was established by the characterization of
IL-15 and IL-15Ra knockout mice which showed a striking lack of memory
phenotype CD8+ T cells (Zhang et al., 1998; Kennedy et al., 2000). Fur-
thermore,memory CD8+ T cells were increased in an IL-15-overexpressing
mouse model (Fehniger et al., 2001). Homeostatic proliferation of T cells
can be one cause for the age-associated loss of CD28 expression, because
CD8+memory T cells in the presence of IL-15 alone, without TCR stimula-
tion, lose CD28 expression and proliferate at a similar rate to CD8+CD28+
T cells (Chiu et al., 2006). IL-15 not only potently induces the proliferation
of memory CD8+ T cells but also augments their effector function by the
induction of perforin expression and cytotoxic properties (White et al.,
2007). Because antigen-specific memory CD4+ T cells have distinct
requirements for homeostatic regulation comparedwith CD8+ T cells, the
role of IL-15 in the maintenance of antigen-specific memory CD4 T cells
was missed by analyses of memory phenotype cells in early studies of
IL-15) ⁄ )mousemodels. Recent studies have shown that IL-15 does in fact
play an appreciable role in CD4+memory T-cell proliferation under physio-
logical conditions (Purton et al., 2007). IL-15 treatment promotes the pro-
liferation of human memory CD4+ T cells in vitro and mouse Ag-specific
CD4+ memory T cells in vivo (Geginat et al., 2001; Lenz et al., 2004).
These findings demonstrate that in a normal environment, memory CD4+
T cells closely resemble memory CD8+ cells in their dependency on IL-15
for their homeostasis (Geginat et al., 2001; Lenz et al., 2004).
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AsCD8+CD28null T cells are highly influencedby IL-15, it is of great inter-
est to determine the responsiveness ofCD4+CD28null T cells to this homeo-
static cytokine, mainly because it has been postulated as a treatment of
T-cell reconstitution in the elderly.Wehave demonstrated in this study that
IL-15 may not only improve CD4+CD28null T-cell expansion but also pro-
mote both their functional properties and their antigen-specific responses.
Results
Effect of IL-15 on CD28 expression in CD4+ T cells
We evaluated the possible effect of IL-15 on the expression of CD28 in
CD4+ T cells from 10 elderly volunteers with percentages of CD28null cells
higher than 5% of total CD4+ T cells. Peripheral blood mononuclear cells
(PBMC) were cultured in the presence and absence of the IL-15 for
7 days. Frequency of CD4+CD28null T cells showed a significant increase
in response to IL-15 treatment compared with cells cultured in medium
alone, with a mean percentage of 15.8 ± 5.1% and 8.6 ± 3.3%, respec-
tively (paired T test, P = 0.00006) (Fig. 1A). In contrast to that described
in CD8+ T cells (Chiu et al., 2006), IL-15 did not induce loss of CD28
expression in CD4+CD28+ T cells in individuals without CD4+CD28null
T-cell subset (data not shown). In spite of their defects in the proliferative
ability (Appay et al., 2002), CD4+CD28null T cells may have increased
owing to an enhanced proliferative response to IL-15 compared with that
of CD28+. To analyze the effect of IL-15 on the proliferation of
CD4+CD28null T cells, PBMC were stained with CFSE and cultured in the
presence of IL-15 for 7 and 14 days. When we compared the growth
kinetics of both populations in response to the cytokine, we found that
CD4+CD28null cells effectively underwent cell division and expansion fas-
ter than did CD4+CD28+ cells. Figure 1B shows a representative experi-
ment in which around 40% of the CD28null cells have divided at least
once after a 7-day culture with IL-15, whereas only 3% of CD28+ cells
did. Differences in frequency of proliferating cells were maintained in the
samples cultured for 14 days, but the number of division cycles was
higher in CD28+ cells.
Differentiating CD4+ T cells first lose expression of CD27, and
subsequently in a later phase, they lose CD28 (Amyes et al., 2003; van
Leeuwen et al., 2004). To characterize the differentiation degree of the
IL-15-generated CD28null T cells, we analyzed the expression of CD27. All
the CD4+CD28null T cells present in the PBMC cultures both in medium
alone and in the presence of IL-15 were also negative for CD27 (Fig. 1C).
Moreover, depending on CD45RA and CCR7 expression, these
CD27nullCD28null cells can be divided into effector memory (EM;
CD45RA)CCR7)) and the most differentiated effector memory RA
(EMRA; CD45RA+CCR7)) subsets (Sallusto et al., 1999). The increase
induced by IL-15 was even more relevant in the EMRA (12.2% ± 8.4% in
medium and 24.9% ± 12.5% with IL-15; paired T cells, P = 0.005) than
in the EM cells (10.8% ± 4.4% in medium and 17.1% ± 8.3% with
IL-15; paired T cells, P = 0.005) (Fig. 1D).
In conclusion, IL-15 increased the frequency of CD4+CD28null T cells
mainly in the highly differentiated subset EMRA by the preferential prolif-
eration of these cells with respect to those expressing CD28.
(A)
(C) (D)
(B)
Fig. 1 Effect of IL-15 on the growth of CD4+CD28null T cells in elderly individuals. (A) Frequency of CD4+CD28null T cells in response to treatment with IL-15. Peripheral
blood mononuclear cells (PBMC) from 10 elderly subjects were cultured in medium or in the presence of IL-15 (50 ng mL)1) for 7 days and analyzed by flow cytometry. Cells
were stained with CD3-FITC ⁄CD28-PE ⁄ CD4-PerCP ⁄CD45-APC, and 5 · 104 cells were acquired in each experiment. Dot plots show the frequencies of CD28+ and CD28null
cells in gated CD4+ T cells in this representative experiment, and the frequencies were averaged from all donors (mean ± SD). (B) Proliferative capacity of CD4+CD28+ and
CD4+CD28null T cells in response to IL-15. PBMC were labeled with CFSE (1.5lM) and cultured in the presence of IL-15 (50 ng mL)1) for 7 and 15 days. CD4+CD28+ and
CD4+CD28null T cells were gated. Percentages of dividing cells were analyzed on days 7 and 15 of culture. Representative histogram plots of cells from one of five experiments
are shown. Histograms depict the mean of the percentages of proliferated (black bar) and nonproliferated (white bar) cells in gated CD4+CD28+ and CD4+CD28null T
lymphocytes in the five experiments. (C) PBMC treated as described above were stained with CD3-FITC ⁄ CD28-PE ⁄ CD4-PerCP ⁄ CD27-APC. Dot plots show the expression of
CD27 and CD28 in gated CD4+ T cells in this representative experiment. (D) Cells were stained with CD45RA-FITC ⁄ CD28-PE ⁄ CD4-PerCP ⁄ CCR7-APC and frequency of
CD28null cells in the EM (CD45RA-CCR7)) and EMRA (CD45RA+CCR7)) CD4+ T-cell subsets was analyzed. Histograms summarize the percentage of CD28null cells in the
indicated cell populations (mean ± SEM) after cells were cultured in medium (white bars) and in the presence of IL-15 (black bars). Paired T test was used to compare paired
frequencies.
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Activation induced by IL-15
To further evaluate other differential effects of IL-15 on CD4+CD28null T
cells compared with CD28+, we studied the expression of several activa-
tion markers in response to the cytokine. Expression patterns of CD127,
CD25, HLA-DR, and CD69 in CD4+CD28+ and CD4+CD28null T cells cul-
tured for 24 h in medium alone and in the presence of IL-15 are repre-
sented in Fig. 2A. IL-15 activation reduced CD127 expression in both
CD28+ and CD28null cells with respect to cells cultured in medium alone
(P = 0.005 and P = 0.002, respectively) (Fig. 2B). CD25 was significantly
increased only in CD28+ cells, whereas CD28null cells showed low CD25
expression both basally and in response to IL-15. On the contrary, IL-15
induced higher expression of HLA-DR and mainly CD69 in CD28null cells
(P = 0.027) with no significant effect on CD28+ cells (Fig. 2B).
We then analyzed the expression of the specific IL-15R a-chain in
CD4+CD28+ and CD4+CD28null T cells to evaluate a possible mechanism
for the different responsiveness of both subsets to IL-15. This receptor
was barely expressed in resting CD4+ T cells and stimulation for 24 h with
IL-15 did not induce up-regulation in CD4+CD28null nor in CD4+CD28+ T
cells (Fig. 3A). To investigate whether there was a difference in intracellu-
lar signaling after IL-15 interaction with its receptor, we analyzed the
STAT-5 activation. As expected, phosphorylation of this signal factor was
strongly induced by IL-15 in both subsets, but CD4+CD28null showed sig-
nificantly higher levels of pSTAT-5 with respect to CD4+CD28+ T cells
(mean: 82.5% ± 6.5% vs. 69.6% ± 7.8%, paired T test, P = 0.036)
(Fig. 3B).
IL-15 induced an activated phenotype in CD4+CD28null T cells, with
enhanced expression of CD69 but diminished CD127 expression. More-
over, the surface expression of IL-15R a-chain was not increased, but
STAT-5 was preferentially activated.
IL-15 up-regulates granzyme B and perforin expression and
cytolytic properties in CD4+CD28null T cells
CD4+ T cells have not been classically considered as cytotoxic cells,
although intracytoplasmic stores of granzyme B and perforin have been
previously described in CD4+CD28null T cells (Appay et al., 2002).
Because IL-15 is known to induce cytotoxic properties in NK and CD8+ T
cells, we analyzed its influence on granzyme B and perforin expression in
CD4+CD28null T cells. After 5 h of culture with IL-15, expression of
both proteins was up-regulated in CD28null cells (Fig. 4A). Percentages
and mean fluorescence intensity (MFI) of perforin-positive cells showed
(A)
(B)
Fig. 2 Effect of IL-15 on the expression of activation markers.
Results were representative for five elderly donors. Peripheral
blood mononuclear cells were cultured for 18 h in the
presence or absence of IL-15. Expression of CD127-PE, CD25-
FITC, HLA-DR-FITC, and CD69-FITC was analyzed in
CD4+CD28+ and CD4+CD28null T cells by flow cytometry.
(A) Histogram plots show a representative experiment of 5
performed. (B) Histograms represent percentage of positive
cells (mean ± SEM) in CD28+ and CD28null cells cultured in
medium (white bars) and in the presence of IL-15 (black bars)
cells. Paired T test was used to compare differences; significant
differences were indicated (*P < 0.05).
(A)
(B)
Fig. 3 Expression of IL-15Ra chain and activation of STAT-5 in response to IL-15.
(A) Peripheral blood mononuclear cells from three elderly donors were cultured in
medium or in the presence of IL-15 (50 ng mL)1) for 24 h. Cells were stained with
CD28-FITC ⁄ IL-15Ra-PE ⁄ CD4-PerCP, and 5 · 104 cells were acquired in each
experiment. Dot plots show the frequencies of expression of IL-15Ra in CD4+ T cells
related to CD28 expression in this representative experiment. (B) CD4+ T cells from
5 elderly subjects were isolated and stimulated with IL-15 for 15 min at 37 C. Cells
were surface-stained with CD28-PE and intracellularly stained with pSTAT5-
AlexaFluor 488. The percentages of pSTAT5-positive cells in CD4+CD28+ and
CD4+CD28null T cells in this representative experiment are expressed in each
histogram plot. Histograms summarize the percentage of positive cells as
mean ± SEM after the culture with IL-15 in the five experiments performed. Paired
T test was used to compare paired frequencies.
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significant differences in CD28null cells treated with IL-15 compared with
cells cultured in medium alone (P = 0.00028 and P = 0.009, respectively)
(Fig. 4B). Similar results were found in the levels of expression
(P = 0.006), but not in the percentage of cells expressing granzyme B
(Fig. 4B). Quantification of granzyme B and perforin mRNA expression by
RT–PCR in purified CD4+ T lymphocytes, with more than 15% of
CD28null cells, also showed higher expression following 5 h of culture
with IL-15 (paired T test, P = 0.028 and P = 0.018, respectively) (Fig. 4C).
Lytic granules consisting of granzymes and perforin are contained in
membrane-bound lysosomes coated with lysosome-associated mem-
brane proteins (LAMPs). LAMPs are not usually present on the surface of
T cells but are exposed only during active degranulation. CD107a (LAMP-
1) expression has been described as a good candidate marker for the
cytotoxic cellular activity (Aktas et al., 2009). Isolated PBMC were cul-
tured in medium or stimulated for 5 h with anti-CD3, IL-15, or both, and
levels of surface CD107a were assessed in CD4+CD28null T cells. Culture
in medium alone or in the presence of IL-15 displayed no effect on
degranulation (Fig. 5A). However, anti-CD3 stimulation induced expres-
sion of CD107a (mean CD107a+ 17.4% ± 4.9%), which was signifi-
cantly increased with the addition of IL-15 (mean 24.5% ± 4.9%)
(P = 0.015).
The effector function of CD4+CD28null T cells (‡ 15% CD28null) was
examined in a redirected cytotoxicity assay against P815 cells previously
coated with anti-CD3 mAbs. CD4+ T cells were isolated and cultured for
6 h with P815 cells in medium with or without IL-15. Cells treated with
IL-15 showed cytotoxicity that was greater than that of medium-cultured
cells at all target–effector cell ratios tested (from 1:1 up to 1:30) (Fig. 5B).
IL-15 showed an increasing effect on cytolytic properties of
CD4+CD28null T cells, both in the expression and storage of involved pro-
teins and in the cytolytic effector functions.
IL-15 enhanced production of IFN-c by CD4+CD28null T cells
in response to specific antigens
CD4+CD28null T lymphocytes have been described as antigen-specific cells
against chronic viral antigens, mainly in some autoimmune diseases (The-
(A)
(C)
(B)
Fig. 4 IL-15 up-regulates granzyme B and perforin expression
in CD4+CD28null T cells. Granzyme B and perforin expression
was studied by intracellular staining in 9 and 7 elderly donors,
respectively, after 5 h of culture in medium in the absence or
presence of IL-15 (50 ng mL)1). (A) Histogram plots show a
representative experiment. (B) Histograms represent the
percentage and the MFI of positive cells (mean ± SEM) in
CD28null cells cultured in medium (white bars) and in the
presence of IL-15 (black bars). (C) Granzyme B and perforin
mRNA expression was determined by quantitative RT–PCR in
isolated CD4+ T cells from six donors cultured for 5 h in
medium (white bars) and in the presence of IL-15 (black bars)
cells. Results were normalized with respect to mRNA
expression in medium. Nonparametric Wilcoxon signed-ranks
test (granzyme B) and paired T test (perforin) were used to
compare differences.
(A)
(B)
Fig. 5 Degranulation and redirected cytotoxicity induced by anti-CD3 and IL-15.
(A) Peripheral blood mononuclear cells from six elderly donors were stimulated with
anti-CD3 (1 lg mL)1), IL-15 (50 ng mL)1), and a combination of both for 5 h.
Surface CD107a expression was analyzed in CD4+CD28null T cells by flow
cytometry. Histograms represent percentage of positive cells (mean ± SEM). Paired
T tests were used to compare differences between medium and Il-15 and between
anti-CD3 and anti-CD3 plus IL-15. (B) Cytotoxicity of purified CD4+CD28null T cells
from three elderly individuals in a redirected cytotoxicity assay was performed as
described in Experimental procedures. Purified CD4+CD28null T cells were cultured
in medium or stimulated with IL-15 for 18 h, and cytotoxicity was measured against
P815 cell line previously labeled with CFSE and coated with anti-CD3 (10 lg mL)1).
Data are shown as the percent lysis that was determined as [(%7-AAD staining
sample – % 7-AAD staining of negative control) ⁄ (100 ·%7-AAD staining of
negative control)] · 100 (mean ± SEM).
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wissen et al., 2007). In order to investigate this point in aging individuals,
the response to chronic and to recent contact antigens was tested. We
compared the induction of CD69 expression in response to CMV antigens
and to influenza vaccine in CD4+ T cells with andwithoutCD28 expression
from a group of 20 elderly subjects (Fig. 6A). These elders were seroposi-
tive for CMV and had been recently vaccinated against the influenza virus.
Their response to CMV did not induce differences in the median value of
CD69-positive cells between the CD4+CD28+ subset at 2% (IR: 4.1%)
and the CD4+CD28null subset at 3% (IR: 3.65%) (Fig. 6A). However,
there were statistically significant differences in response to influenza vac-
cine (Mann–Whitney U test, P = 0.00013), with 4.5% (IR: 10.9%) of
CD4+CD28+ T cells expressing CD69 and only 0.67% (IR: 1.47%) of
CD4+CD28null T cells (Fig. 6A). To evaluate the effect of IL-15 on the anti-
gen-specific response to chronic CMV infection, the cells were precultured
for 18 hwith IL-15 or inmediumalone and then stimulatedwith an extract
of CMV for 18 h. Both CD4+CD28+ and CD4+CD28null T cells produced
measurable levels of IFN-c in response to IL-15 and to CMV; nevertheless,
differenceswith cells cultured inmediumalonewere not statistically signif-
icant (Fig. 6B). CD4+CD28null T cells pretreated with IL-15 and stimulated
with CMV displayed the highest frequencies of IFN-c-producing cells
(P < 0.05, compared with all other stimulation conditions), showing a
greater than additive effect and potentially a synergistic effect which was
not observed in CD4+CD28+ T cells (Fig. 6B).
CD4+CD28null T cells were mainly specific against chronic contact anti-
gens, and pretreatment with IL-15 enhanced their antigen-specific
responses.
Discussion
The effect of IL-15 was thought to be more pronounced in the CD8+ than
in the CD4+ T-cell compartment. Nevertheless, to our knowledge, this is
the first study demonstrating that IL-15 displays a striking effect on CD4+
T cells, with greater capacity for activating CD28null cells than CD28+
cells. IL-15 increases the proliferation and frequency of CD4+CD28null T
cells, compared with CD4+CD28+ T cells. Moreover, activation is clearly
induced by IL-15 on CD4+CD28null T cells as shown by both expression of
activation markers and an enhancing effect on their cytolytic properties.
Pretreatment with IL-15 also enhances the IFN-c production in the anti-
gen-specific responses of CD28null T cells with minimal effects on CD28+
cells. These effects of IL-15 may be important because the accumulation
of CD28null T cells is associated with reduced overall immune responses to
pathogens and vaccines in the elderly(Saurwein-Teissl et al., 2002) and
IL-15 could potentially be useful in enhancing the antigen-specific
response of CD4+CD28null T cells.
A progressive increase in the percentage of T cells that lack CD28
expression is common with increasing age in healthy individuals (Goronzy
et al., 2007; Czesnikiewicz-Guzik et al., 2008) and in patients with
chronic infections and autoimmune diseases (Komocsi et al., 2002; Effros
et al., 2005; Fletcher et al., 2005; Thewissen et al., 2007; Alonso-Arias
et al., 2009). These cells have a memory phenotype, are long-lived in vivo,
display reduced diversity of the T-cell receptor (TCR), and have reduced
division potential (Vallejo et al., 1999, 2000; Appay et al., 2002). At the
same time, they express perforin and granzyme B, which confer cytotoxic
(A)
(B)
Fig. 6 CD4+CD28+ and CD4+CD28null T-cell antigen-specific response to chronic and recent contact antigens. (A) CD69 expression in response to CMV antigens and to the
influenza vaccine. Whole blood from elderly individuals were stimulated for 18 h with CMV (104 PFU mL)1) or influenza vaccine (dilution 1 ⁄ 100), and CD69 expression was
evaluated by flow cytometry. Dispersion plots summarize the percentage of CD69+ cells for CMV and influenza vaccine in the CD4+CD28+ and CD4+CD28null subsets
obtained from 20 elderly donors. Paired T test was used to compare paired frequencies. (B) Peripheral blood mononuclear cells were precultured for 18 h in medium or in the
presence of IL-15 (50 ng mL)1), washed, and cultured for 6 h in medium or with CMV (104 PFU mL)1). The responder cells in the CD4+CD28+ and CD4+CD28null T-cell
subsets were analyzed for intracellular IFN-c staining. Percentages of IFN-c-positive cells in the indicated populations in this representative experiment are expressed on the
dot plots. Histograms summarize the percentage of IFN-c-positive cells in both subsets (mean ± SEM) from the five elderly donors tested. Paired T test was used to compare
paired means (*represent P < 0.05 with respect all other conditions).
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ability and the capability to produce large amounts of IFN-c (Appay et al.,
2002; van Leeuwen et al., 2004; Alonso-Arias et al., 2011). The data sug-
gest that the loss of CD28 expression is induced by repeated exposure to
the same antigens such as CMV or other persistent viral infections;
chronic CMV represents a model of antigen persistence with transient
reactivations mainly in immunosuppressed individuals (Appay et al.,
2002; Goronzy & Weyand, 2005). The cause of loss of CD28 expression
in T cells with age has been attributed to repeated antigenic stimulation
(Valenzuela & Effros, 2002; Vallejo, 2005), and it is now accepted that
CD28null T cells have experienced past episodes of activation and cell
cycling. However, the loss of CD28 can result not only from repeated TCR
activation but also from homeostatic proliferation. IL-15-mediated prolif-
eration, without antigenic stimulation, results in a stable loss of CD28
expression in CD8+ memory T cells in part through the induction of TNF-a
secretion (Chiu et al., 2006). In this study, we failed to demonstrate a
similar effect of IL-15 on CD4+ T cells because IL-15 did not induce loss of
CD28 expression in CD4+CD28+ T cells in our culture conditions. Despite
this, we found a significant increase in the proportion of CD4+ T cells
without CD28 expression, which was attributable to an enhanced prolif-
erative response to IL-15 of the CD4+CD28null T cells with respect to
CD4+CD28+ T cells. IL-15 might be able to counteract the widely
described defects in the proliferative ability of CD28null T cells (Appay
et al., 2002), even in the most differentiated EMRA cells. The possible role
of this cytokine in the maintenance of CD28null T cells in vivo was previ-
ously suggested because CD8+CD28null T cells also exhibited normal
growth under IL-15 stimulation in vitro (Chiu et al., 2006).
There are no differences in the serum levels of IL-15 between old and
young controls (Gangemi et al., 2005), and PBMC from aged donors pro-
duced IL-15 in vitro at levels similar to those found in the young (Tortorel-
la et al., 2002). However, IL-15 is overproduced in some inflammatory
and autoimmune diseases, and it has been speculated that chronic expo-
sure to this cytokine is likely the mechanism of the expansion of
CD4+CD28null T cell in vivo (Yamada et al., 2007). In the case of rheuma-
toid arthritis, the best characterized disease in which IL-15 is of substantial
clinical importance, the levels of the cytokine are elevated in the patients
correlating with the disease severity (McInnes et al., 1997). Simulta-
neously, the progression of the pathology is thought to be accompanied
by the recruitment and rise of oligoclonal, autoreactive CD4+CD28null T
cells, suggesting the potential relevance of IL-15 in this expansion.
Nevertheless, the CD4+CD28null population express activation markers
with little or no evidence of proliferation (Appay et al., 2002) and present
a low activation threshold in response to TCR stimulation, which could be
implicated in its predisposition to the breakdown of self-tolerance (Yung
et al., 1996). Similarly, we corroborated the activating effect of IL-15 on
CD4+ T cells in short-term cultures. An activated phenotype was induced
in both subsets of CD4+ T cells, with the most notable differences in the
expression of CD69 and CD127 in the CD28null cells. CD69 displayed a
clear up-regulation, whereas the percentage of cells expressing CD127,
the IL-7 receptor which is down-regulated on all human T cells after acti-
vation, was decreased by nearly half. Whereas IL-15 has minimal effect
on the expression of other c-chain cytokine receptors in CD28null cells,
such as IL-2 and IL-15 (Alves et al., 2005), the expression of CD127 in
CD8+ T cells is decreased after stimulation with IL-15. IL-15 binds to a tri-
meric receptor composed of the cc chain, the IL-2 ⁄ IL-15 b-chain (CD122),
and the unique IL-15R a-chain. IL-15Ra is barely expressed in naı¨ve CD8+
T cells and completely down-regulated in cultures where IL-15 is present
(Alves et al., 2003). It has been shown that the IL-15R a-chain is dispens-
able on CD8+ T cells for IL-15-mediated proliferation (Dubois et al.,
2002). In CD4+ T cells, we found that an increase in receptor expression
is not necessary to induce the activation of STAT5, the downstream sig-
naling molecule used by IL-15. It has been postulated that CD4+ memory
T cells rely on STAT5 considerably more than do effector CD4+ T cells
(Purton et al., 2007; Tripathi et al., 2010). Accordingly, we have found
the activating effect of IL-15 on STAT5 was more prominent on CD28null
than on CD28+ CD4+ T cells. IL-15 increased the cytolytic properties of
CD4+CD28null T cells and enhanced their antigen-specific responses.
Granzyme B and perforin expression in CD4+ T cells is closely associated
with the loss of CD28 on the cell surface. These CD4+CD28null T cells
resembled cytotoxic CD8+ T cells, because their cytotoxic capacity is med-
iated by TCR stimulation. In addition, they lack costimulatory molecule
requirements (Appay et al., 2002). Similar to our findings in
CD4+CD28null T cells, in CD8 T cells, IL-15 may regulate perforin expres-
sion at the level of transcription through STAT5 activation, and it aug-
ments anti-CD3-induced degranulation, in agreement with the induction
of cytotoxic activity (Weng et al., 2002). Although the role of CD4+ T
cells as cytotoxic effector cells is not well known, the enhancing effector
activity of IL-15 may have much impact, because CD4+CD28null T cells
were mainly specific against chronic contact antigens. IL-15 plays a critical
role in the immune responses to early infection and chronic inflammation
by amplifying the effects of proinflammatory cytokines on IFN-c secretion
(Smeltz, 2007). In this way, pretreatment with IL-15 enhanced the anti-
gen-specific responses of CD4+CD28null, increasing the frequencies of
IFN-c-producing cells, but exerted no synergistic effect on CD4+CD28+ T
cells. IFN-c production from CD4+CD28null T cells is induced at much
lower doses of anti-CD3 than in their CD28+ counterparts and is also
independent of costimulation (Alonso-Arias et al., 2011).
It has been hypothesized that CD4+CD28null T cells might be playing a
role in containing viral infections tropic for HLA class II cells, such as EBV
in B cells, HIV-1 in activated CD4+ T cells, monocytes and dendritic cells,
and CMV in endothelial cells, although the mechanism of this antigen
presentation is unknown at this time. In the case of CMV infection, endo-
thelial cells are poor antigen-presenting cells under normal conditions in a
classical immune response because they lack costimulatory molecules.
But because the CD28null T cells do not require costimulation and present
a low activation threshold, antigen presentation could be effective by
nonprofessional cells such as endothelial cells. This hypothesis is sup-
ported by the fact that the class II pathway may be preferentially targeted
because both EBV and CMV prevent normal MHC class I expression as
part of their strategies of immune evasion (Alcami & Koszinowski, 2000).
In summary, our data show that IL-15 plays a role in enhancing activa-
tion, proliferation, and the effector response of CD4+CD28null T cells
against their specific antigens. This may be mainly relevant in the elderly
immune system characterized by lower adaptive responses, and treat-
ment with IL-15 has been proposed as a strategy to alleviate the effects
of T-cell deficiencies and to improve the immune function.
Experimental procedures
Donors
Blood samples were obtained from elderly donors in the Hospital Universi-
tario Central de Asturias and the Monte Naranco Hospital (Oviedo,
Spain). The volunteers were not rigorously selected according to their
health status in order to study a representative sample from the popula-
tion. However, those volunteers with serious diseases such as cancer,
chronic diseases (diabetes, autoimmune diseases), or congestive heart
failure and those receiving ongoing treatment with immunosuppressive
drugs were excluded from participation. Samples from 45 elderly donors
(‡ 65 years, mean age: 76 ± 6 years) were analyzed in the study to deter-
mine whether they met the inclusion criteria of the presence of
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CD4+CD28null T cells at > 5% of total CD4+ T cells (n = 30). Informed
consent was obtained from donors prior to participation in the study. The
study was approved by the Hospital Central de Asturias (Oviedo, Spain)
ethics committee.
Quantification of CD4+CD28null T cells
The percentage of CD4+CD28null T cells was determined in peripheral
blood from the elderly participants by staining with anti-CD3 (FITC), anti-
CD28 (PE) (eBioscience, San Diego, CA, USA), anti-CD4 (PerCP), and anti-
CD45 (APC) (Immunostep, Salamanca, Spain). One hundred microliters
of whole blood from elderly was stained with the combination of labeled
monoclonal antibodies for 30 min at room temperature. Samples were
red blood lysed with FACS Lysing Solution (BD Biosciences, San Jose´, CA,
USA), washed in PBS, and analyzed with CellQuest software in the FAC-
SCalibur Cytometer (BD Biosciences). Appropriate isotype control mono-
clonal (mAbs) were used for marker settings. CaliBRITE Beads (BD
Biosciences) were used to adjust instrument settings, set fluorescence
compensation, and check instrument sensitivity. BD Multicheck Control
and Multicheck CD4 Low Control were used as quality controls.
Isolation of PBMC and cell cultures
Peripheral blood mononuclear cells were isolated from peripheral blood
that had been anticoagulated with EDTA by centrifugation on Ficoll-Hyp-
aque gradients (Lymphoprep; Nycomed, Oslo, Norway). Cultures were
performed in RPMI 1640 medium containing 2 · 10)3M L-glutamine and
Hepes (BioWhitaker, Verviers, Belgium) and supplemented with 10% FCS
(ICN Flow; Costa Mesa, CA, USA) and antibiotics. Cells were incubated at
37 C and 5% carbon dioxide.
Stimulation with IL-15
Peripheral blood mononuclear cells (4 · 106 cells mL)1) were cultured
in the presence and absence of IL-15 (50 ng mL)1) (Peprotech INC,
Rockyhill, NJ, USA) for different times. Frequencies of CD4+CD28null T
cells were quantified after 7 days of culture with the same combination
of labeled antibodies described earlier. Additional staining was per-
formed with anti-CD27 (APC) (eBioscience), anti-CCR7 (Alexa Fluor
647) (BD Bioscience), and CD45RA (FITC) (Immunostep). To analyze an
activated phenotype, cells were cultured for 18 h and then stained with
anti-CD3 (APC), anti-CD28 (FITC or PE), anti-CD69 (FITC), (eBioscience),
anti-CD4 (PerCP), anti-CD127 (PE), anti-IL-15R a-chain (eBioscience), anti-
HLA-DR (FITC), and anti-CD25 (PE) (BD Bioscience). Frequencies of cells
with intracytoplasmic stores of granzyme B and perforin in
CD4+CD28null T cells after 6 h of culture with IL-15 were measured.
Cells were surface-stained for 30 min at room temperature, lysed and
fixed with FACS lysing solution, permeabilized with BD FACS Permeabi-
lizing Solution 2 (Perm II) (BD Bioscience), and stained with anti-gran-
zyme B (FITC) or anti-perforin (FITC) (BD Bioscience) for 30 min at
room temperature. Cells were washed and resuspended in 1% para-
formaldehyde until FACS analysis.
Proliferation assays
Peripheral blood mononuclear cells were resuspended in PBS at a final
concentration of 5–10 · 106 cells mL)1 and incubated with 1.5 lM CFSE
(Invitrogen, Paisley, Scotland, UK) for 10 min at 37 C, washed with RPMI
1640 medium containing 2 · 10)3M L-glutamine and Hepes twice, and
cultured at 2 · 106 cells mL)1 in the presence of human recombinant IL-
15 (50 ng mL)1). The proliferative responses of CD4+ and CD8+ T cells
were analyzed on days 7 and 14 by FACSCalibur after staining with anti-
CD4 (PerCP) and anti-CD28 (PE).
mRNA quantification
CD4+ T cells from individuals with more than 15% CD4+CD28null T cells
were isolated (Myltenyi Biotec GmbH, Bergisch Gladbach, Germany).
mRNA was extracted using a Total RNA Isolation (Macherey-Nagel GmbH
& CoKG, Du¨ren, Germany) according to the manufacturer’s instructions.
Reverse transcription of mRNA isolated from each sample was carried out
in a 20-lL final volume with the iScript cDNA Synthesis Kit (Bio-Rad, Life
Science Research Group, Hercules, CA, USA) following manufacturer’s
instructions. The mixture was incubated at 25ºC for 5 min, at 42 C for
30 min, and at 85 C for 5 min and stored at )80 C until required for
PCR.
Quantification of perforin and granzyme B expression was performed
using SYBR Green real-time quantitative PCR and an iCycler thermocy-
cler (Bio-Rad) with the previously described primers (Morissette et al.,
2007). Briefly, a calibration curve was generated with serial dilutions of
granzyme B and perforin and GAPDH external standards that allowed
the quantification of cDNA samples, leading to the determination of
mRNA relative units. Reactions without cDNA were always included as
a negative control, and cDNA samples were quantified in duplicate.
External granzyme B and perforin standards were serial dilutions of the
cDNA obtained from CD8+ T cells stimulated for 3 h with anti-CD3
(1 lg mL)1). Thermal cycling conditions began with 50 C for 2 min
and 94 C for 15 min, followed by 40 cycles of 94 C for 15 s, 58 C
for 30 s, and 72 C for 1 min. Experimental samples were run in dupli-
cate, and the replicate average value was recorded as the sample
result.
STAT5 quantification
Isolated CD4+ T cells were stimulated with IL-15 recombinant protein
(50 ng mL)1) for 15 min at 37C. Cells were fixed using BD Cytofix Fixa-
tion Buffer (10 min at 37C), stained on the surface with anti-CD28 (PE),
and permeabilized in BD Phosflow Perm Buffer III (30 min on ice). Cells
were then washed twice in BD Pharmingen Stain Buffer and stained with
20 lL Alexa Fluor 488-conjugated phospho-Stat5 antibody for 1 h at
room temperature. The cells were analyzed on a BD FACSCalibur flow
cytometer.
Lysosomal degranulation assay
CD107a lysosome-associated membrane protein-1 (LAMP-1) expression
was used to measure CD4+ T-cell degranulation. PBMC were incubated
for 5 h in medium alone, IL-15 (50 ng mL)1), anti-CD3 (1 lg mL)1) (eBio-
science), and IL-15 plus anti-CD3. After the first hour of culture, monen-
sin (2 lM) (BD Biosciences), a protector of the cell degranulation, was
added. Cells were then stained with anti-CD28 (FITC), anti-CD4 (PerCP),
and CD107a antibody (Alexa Fluor 647) (eBioscience). All samples were
analyzed with CellQuest software in the FACSCalibur Cytometer.
Redirected cytotoxicity assay
Peripheral blood mononuclear cells were separated from the blood of
three elderly individuals with > 20% CD4+CD28null T cells. Isolated
CD4+ T cells (Miltenyi Biotec GmbH) were stained with anti-CD28-PE,
and CD28null cells were also isolated by negative selection with anti-PE
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magnetic microbeads (Miltenyi Biotec GmbH). Cytotoxicity of T-cell sub-
sets was determined as previously described (Lecoeur et al., 2001).
Briefly, purified CD4+CD28null T cells from donors were cultured in
medium with or without IL-15 for 18 h as a source of effector cells and
resuspended at appropriate concentrations for the desired effector–tar-
get cell (E ⁄ T) ratio. Target cells (P815) were labeled with CFSE and
washed three times in complete medium. The P815 cells were then
incubated for 30 min on ice with 10 lg mL)1 of anti-CD3 mAb, resus-
pended in medium, and adjusted to 105 cells mL)1. Effector cells were
added to 100 lL target cells in round-bottom polystyrene tubes (BD
Biosciences) to yield E ⁄ T ratios of 1:1, 1:5, 1:15, and 1:30, mixed by
gentle tapping, incubated at 37 C for 4 h, and stained with 5 lL 7-
ADD (Immunostep) for 20 min before data acquisition. Percentage of
lysis was determined as [(%7-AAD+ cells in test sample – % 7-ADD+
cells in negative control) ⁄ (100 · %7-ADD+ cells in negative con-
trol)] · 100.
Antigen-specific stimulation
Antigen-specific responses were analyzed in PBMC from CMV-seroposi-
tive individuals vaccinated with a trivalent influenza vaccine (Solvay Bio-
logicals BV, Olst, Holland). CMV-infected cell lysate was prepared by
infecting human embryonic lung fibroblasts with the AD169 strain of
CMV. Viral titers in the supernatant were determined by standard plaque
assays. The virus was inactivated by repeated freeze–thaw cycles. Hepa-
rinized venous blood samples were stimulated with CMV (104 PFU mL)1)
or a 1 ⁄ 100 dilution of the influenza vaccine (Solvay Biologicals BV) in 15-
mL conical polypropylene tubes in a humidified 37 C incubator for 18 h.
Activation was assessed by surface staining with anti-CD69. The cells
were also stained with anti-CD3, anti-CD4, and anti-CD28. Samples were
red blood cell lysed with FACS lysing solution, washed in PBS, and ana-
lyzed with CellQuest software.
To quantify IFN-c production, PBMC (4 · 106 cells mL)1) were precul-
tured for 18 h in medium or in the presence of IL-15 (50 ng mL)1),
washed, and cultured again in medium or with CMV (104 PFU mL)1) for
6 h. Cultures for the detection of intracytoplasmic cytokines were treated
after the first 2 h with the secretion inhibitor Brefeldin A (10 lg mL)1)
(Calbiochem, Darmstadt, Germany). After four additional hours, cells
were treated with 2 mM EDTA for 15 min at room temperature, washed,
and stained with antibodies against CD4 and CD28 at 4 C. Intracellular
staining of anti-IFN-c (BD Biosciences) was performed as previously
described for granzyme B and perforin.
Virological testing
Immunoglobulin G levels of CMV-specific antibodies were determined by
enzyme-linked immunosorbent assay Vir-ELISA Anti-CMV-IgG (Viro-Im-
mun Labor-Diagnostika GmbH, Oberursel, Germany) according to the
manufacturer’s specifications. Patient samples were quantified and inter-
preted by means of the calculation of the ratio (Cutoff Index = OD value
of sample ⁄ cutoff value), whereby a ratio of 1.0 is equivalent to the cutoff
value. Cutoff indexes > 1.1 were considered positive.
Statistical analysis
Comparisons between groups were performed with the nonparametric
Wilcoxon signed-rank test when data were not normally distributed or
with Student’s t test for paired data. Analyses were performed using the
SPSS 15.0 statistical software package program (SPSS Inc., Chicago, IL,
USA). P-values of 0.05 or less were considered significant.
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